We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A federal appeals court ruled that Praxair could not have infringed on five Mallinckrodt patents for inhaled nitric oxide because the patents were invalid. Read More
The FDA shared its latest thinking on the use of placebos in oncology trials in a final guidance released Wednesday, highlighting ethical concerns about the use of “sham surgical procedures.” Read More
Purdue confirmed that it’s working on a settlement deal to bury thousands of lawsuits alleging the company is responsible for the opioid crisis. While it didn’t confirm a proposed settlement amount, sources close to the talks cited a figure of $10 to $12 billion. Read More
The judge said HHS “lacks the statutory authority under the Social Security Act … to issue a rule that compels drug manufacturers to disclose list prices.” Read More